1.
Maher AR. Efficacy and Comparative Effectiveness of Atypical Antipsychotic Medications for Off-Label Uses in AdultsA Systematic Review and Meta-analysis. JAMA: The Journal of the American Medical Association. 2011 Sep 28;306(12).
2.
Clinical guidelines, CG42 - Issued: November 2006 [Internet]. Available from: http://guidance.nice.org.uk/CG42
3.
TA217 Alzheimer’s disease - donepezil, galantamine, rivastigmine and memantine: guidance (MS Word format) [Internet]. Available from: http://guidance.nice.org.uk/TA217/Guidance/doc/English
4.
Exelon - Summary of Product Characteristics (SPC) - (eMC) [Internet]. Available from: https://www.medicines.org.uk/emc/search?q=Exelon+
5.
Aricept Tablets - Summary of Product Characteristics (SPC) - (eMC) [Internet]. Available from: http://www.medicines.org.uk/emc/medicine/577/SPC/Aricept
6.
Reminyl Tablets - Summary of Product Characteristics (SPC) - (eMC).
7.
Ebixa 5mg/pump actuation oral solution, 20mg and 10 mg Tablets and Treatment Initiation Pack - Summary of Product Characteristics (SPC) - (eMC) [Internet]. Available from: http://www.medicines.org.uk/EMC/medicine/10175/SPC/rEbxia+5mg+pump+oral+solution%252c+20mg+and+10+mg+tablets+and+Treatment+Initiation+Pack/
8.
DH Living well with dementia: a National Dementia Strategy [Internet]. Available from: https://www.gov.uk/government/organisations/department-of-health
9.
British National Formulary [Internet]. Available from: http://www.bnf.org/bnf/index.htm
10.
Bhasin M, Rowan E, Edwards K, McKeith I. Cholinesterase inhibitors in dementia with Lewy bodies—a comparative analysis. International Journal of Geriatric Psychiatry. 2007 Sep;22(9):890–895.
11.
Kavirajan H, Schneider LS. Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials. The Lancet Neurology. 2007 Sep;6(9):782–792.
12.
Warner J, Smith T. The rise and fall of antipsychotic prescribing in dementia. Where do we go from here? The rise and fall of antipsychotic prescribing in dementia. Signpost; 14(2):24–27.
13.
Sube Banerjee. The use of antipsychotic medication for people with dementia: Time for action. A report for the Minister of State for Care Services [Internet]. 12AD. Available from: http://psychrights.org/research/digest/nlps/BanerjeeReportOnGeriatricNeurolepticUse.pdf
14.
Optimising treatment and care for behavioural and psychological symptoms of dementia: A best practice guide [Internet]. Available from: https://www.alzheimers.org.uk/bpsdguide
15.
Treatment protocol by NHS Medway: Treatment of  Behaviour That Challenges [Internet]. Available from: http://www.kmpt.nhs.uk/policies
16.
Antipsychotics increase mortality in elderly patients with dementia [Internet]. Available from: http://www.npc.nhs.uk/merec/cns/dementia/merec_extra_no39.php
17.
Electronic Medicines Compendium (eMC) [Internet]. Available from: http://www.medicines.org.uk/emc/
18.
Pierre N. Tariot, M.D.; Rosemary Erb, R.N., B.S.N.; Carol Ann Podgorski, Ph.D.; Christopher Cox, Ph.D.; Shirish Patel, M.D.; Laura Jakimovich, M.S., R.N.; Carrie Irvine, B.A. Efficacy and Tolerability of Carbamazepine for Agitation and Aggression in Dementia. PsychiatryOnline | American Journal of Psychiatry | Efficacy and Tolerability of Carbamazepine for Agitation and Aggression in Dementia. 1998;155(1):54–61.
19.
Martinón-Torres G, Fioravanti M, Grimley Evans J. Trazodone for agitation in dementia. Cochrane Database of Systematic Reviews. 2004 Jul 19;
20.
Electronic Medicines Compendium (eMC) [Internet]. Available from: http://www.medicines.org.uk/emc/
21.
Risperdal Tablets, Liquid & Quicklet - Summary of Product Characteristics (SPC) - (eMC) [Internet]. Available from: http://www.medicines.org.uk/emc/document.aspx?documentid=12818&docType=SPC
22.
Maher AR, Maglione M, Bagley S, Suttorp M, Hu JH, Ewing B, Wang Z, Timmer M, Sultzer D, Shekelle PG. Efficacy and Comparative Effectiveness of Atypical Antipsychotic Medications for Off-Label Uses in Adults. JAMA. 2011 Sep 28;306(12).
23.
Complete Guide to Behavioural and Psychological symptoms of Dementia [Internet]. Available from: http://www.ipa-online.org/
24.
Waldemar G, Hyvärinen M, Josiassen MK, Kørner A, Lehto H, Wetterberg P. Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer’s disease. International Journal of Geriatric Psychiatry. 2008 Sep;23(9):979–981.
25.
Electronic Medicines Compendium (eMC) [Internet]. Available from: https://www.medicines.org.uk/emc/
26.
Evidence Search - Search Engine for Evidence in Health and Social Care [Internet]. Available from: https://www.evidence.nhs.uk/
27.
Evidence Search - Search Engine for Evidence in Health and Social Care [Internet]. Available from: https://www.evidence.nhs.uk/
28.
Map of Medicine | Home [Internet]. Available from: http://www.mapofmedicine.com/
29.
Medicines Information - Evidence Search - Search Engine for Evidence in Health and Social Care [Internet]. Available from: https://www.evidence.nhs.uk/
30.
NPC | National Prescribing Centre [Internet]. Available from: https://www.guidelinesinpractice.co.uk
31.
National Institute for Health and Care Excellence [Internet]. Available from: http://www.nice.org.uk/
32.
NICE Clinical Knowledge Summaries (CKS) [Internet]. Available from: http://cks.nice.org.uk/
33.
Scottish Intercollegiate Guidelines Network (SIGN) [Internet]. Available from: http://www.sign.ac.uk/
34.
Centre for Medicines Optimisation - MTRAC | Independent Medicines Review | Midlands Therapeutics Review & Advisory Committee | Centre for Medicines Optimisation | Keele University [Internet]. Available from: http://centreformedicinesoptimisation.co.uk/mtrac/
35.
NPC | National Prescribing Centre [Internet]. Available from: https://www.guidelinesinpractice.co.uk
36.
Evidence Search - Search Engine for Evidence in Health and Social Care [Internet]. Available from: https://www.evidence.nhs.uk/
37.
GOV.UK [Internet]. Available from: https://www.gov.uk/government/organisations/department-of-health
38.
Miller WR, Rollnick S. Motivational interviewing: helping people change. 3rd ed. New York: Guilford Press; 2013.
39.
Prochaska JO, Norcross JC, DiClemente CC. Changing for good. New York: William Morrow; 1994.
40.
Rollnick S, Mason P, Butler C. Health behavior change: a guide for practitioners. Edinburgh: Churchill Livingstone; 1999.
41.
Rollnick S, Miller WR, Butler C. Motivational interviewing in health care: helping patients change behavior. New York: Guilford Press; 2008.
42.
Hubley J, Copeman J, Woodall J. Practical health promotion. 2nd ed. Cambridge: Polity Press; 2013.
43.
Laverack G. Health promotion practice: building empowered communities [Internet]. Maidenhead: Open University Press; 2007. Available from: https://search.ebscohost.com/login.aspx?direct=true&AuthType=ip,shib&db=nlebk&AN=234222&site=ehost-live&scope=site&custid=s8454451
44.
Macdowall W, Bonell C, Davies M. Health promotion practice. Maidenhead: Open University Press; 2006.
45.
Walker R, Whittlesea C. Clinical pharmacy and therapeutics [Internet]. 5th ed. Edinburgh: Churchill Livingstone; 2012. Available from: https://www.vlebooks.com/Product/Index/173020?page=0&startBookmarkId=-1
46.
Kumar PJ, Clark ML. Kumar & Clark’s clinical medicine [Internet]. 8th ed. Edinburgh: Saunders Elsevier; 2012. Available from: https://www.dawsonera.com/abstract/9780702053047
47.
Greene RJ, Harris ND. Pathology and therapeutics for pharmacists: a basis for clinical pharmacy practice. 3rd ed. London: Pharmaceutical Press; 2008.
48.
Coeliac disease: recognition, assessment and management  | Guidance and guidelines | NICE. NICE; Available from: https://www.nice.org.uk/guidance/ng20
49.
Chronic obstructive pulmonary disease [Internet]. Available from: http://cks.nice.org.uk/chronic-obstructive-pulmonary-disease
50.
CPPE - Centre for Pharmacy Postgraduate Education [Internet]. Available from: https://www.cppe.ac.uk/
51.
Royal Pharmaceutical Society (RPS) [Internet]. Available from: http://www.rpharms.com/home/home.asp
52.
Heart failure - chronic [Internet]. Available from: http://cks.nice.org.uk/heart-failure-chronic
53.
Medicines Use Review and Prescription Intervention service [Internet]. Available from: http://psnc.org.uk/wp-content/uploads/2013/06/MUR-service-spec-Aug-2013-changes_FINAL.pdf
54.
Service specification - New Medicine Service (NMS) [Internet]. Available from: http://psnc.org.uk/wp-content/uploads/2013/06/NMS-service-spec-Aug-2013-changes_FINAL.pdf
55.
Commissioners and healthcare professionals - Training videos [Internet]. Available from: http://healthcheck.nhs.uk/commissioners_and_providers/training/training_videos1/
56.
NHS Health Check - NHS Choices [Internet]. Available from: http://www.nhs.uk/Conditions/nhs-health-check/Pages/NHS-Health-Check.aspx